SEC Form 4 research

Rapport Therapeutics, Inc. insider transactions

IssuerRapport Therapeutics, Inc.
TickersRAPP
Reporting owners30
Officers and directors16
Last public filing2026-11-03

Recent insider disclosures

AvailableTrade dateReporting ownersCodeSharesPriceReported value
2026-11-032026-10-30TRV GP V, LLC, TRV GP VI, LLC, Third Rock Ventures GP V, LP, Third Rock Ventures GP VI, L.P., Third Rock Ventures V, L.P., Third Rock Ventures VI, L.P.A1,190,476$21Not reported
2026-11-032026-10-30TRV GP V, LLC, TRV GP VI, LLC, Third Rock Ventures GP V, LP, Third Rock Ventures GP VI, L.P., Third Rock Ventures V, L.P., Third Rock Ventures VI, L.P.A238,095$21Not reported
2026-10-302026-10-28HEALY JAMESP6,933$21Not reported
2026-10-302026-10-28HEALY JAMESP3,772$21Not reported
2026-10-302026-10-28HEALY JAMESP6,395$21Not reported
2026-10-302026-10-28HEALY JAMESP952,380$21Not reported
2026-10-232026-10-21Ceesay AbrahamS2,210$29.16Not reported
2026-10-232026-10-23Sanchez RamiroP3,600$27.35Not reported
2026-10-222026-10-22Silva Paul MP3,680$27.08Not reported
2026-10-222026-10-22Young Wendy B.P3,789$26.39Not reported

Officers and directors in the directory

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page